株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の医薬品原薬(API)市場

Global Active Pharmaceutical Ingredients Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 250546
出版日 ページ情報 英文 119 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
世界の医薬品原薬(API)市場 Global Active Pharmaceutical Ingredients Market 2015-2019
出版日: 2014年12月10日 ページ情報: 英文 119 Pages
概要

2014年から2019年の世界における医薬品原薬(API)市場のCAGR(複合年間成長率)は、7.48%となることが予測されています。

当レポートでは、世界における医薬品原薬(API)市場の動向や将来予測、成長因子と課題、主要ベンダーの分析などの情報を提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要

第7章 世界の医薬品原薬(API)市場

  • 市場規模と予測
  • ファイブフォース分析

第8章 生産プロセスタイプ別の市場区分

  • 合成医薬品原薬
  • バイオ医薬品原薬

第9章 製品タイプ別の市場区分

  • 高薬理活性原薬(HPAPI)

第10章 プレイヤータイプ別の市場区分

第11章 地理区分

  • 南北アメリカ
  • アジア太平洋地域
  • 欧州・中東・アフリカ地域

第12章 主要国

第13章 購入基準

第14章 市場成長因子

第15章 成長因子とその影響

第16章 市場の課題

第17章 成長因子と課題の影響

第18章 市場動向

第19章 動向とその影響

第20章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
  • 主要ベンダー
  • その他の有力ベンダー
    • Abbott Laboratories
    • Actavis
    • Aesica
    • Albemarle
    • AMPAC Fine Chemicals
    • Anhui Biochem United Pharmaceutical
    • Anuh Pharma
    • Aptuit
    • AstraZeneca
    • Biocon
    • Bristol-Myers Squibb
    • Calyx Chemicals & Pharmaceuticals
    • Cambrex
    • Cilag
    • CIRON Drugs and Pharmaceuticals
    • CTX Life Sciences
    • Dishman Pharmaceuticals & Chemicals
    • Dr. Paul Lohmann
    • Emcure Pharmaceuticals
    • Farmabios
    • F. Hoffmann-La Roche
    • GlaxoSmithKline
    • Guilin Pharmaceutical
    • Hetero Drugs
    • Hospira
    • Ipca Laboratories
    • Janssen Pharmaceutica
    • Johnson Matthey
    • Laurus Labs
    • Lupin
    • Mallinckrodt Pharmaceuticals
    • Mangalam Drugs & Organics
    • Merck
    • Mylan
    • Novartis
    • Novasep
    • Pen Tsao Chemical Industry
    • Pfizer
    • Ranbaxy Laboratories
    • Royal DSM
    • Sanofi-Aventis
    • Sequent Scientific
    • Shanghai Desano Chemical Pharmaceutical
    • Shasun
    • Shijiazhuang Lonzeal Pharmaceuticals
    • Sigma-Aldrich
    • ST Pharm
    • Sun Pharmaceutical Industries
    • WuXi AppTec
    • Zhejiang Langhua Pharmaceutical
    • Zhuhai Rundu Pharmaceutical

第21章 主要ベンダーの分析

  • Aurobindo Pharma
  • BASF
  • Boehringer Ingelheim
  • Cipla
  • Dr. Reddy's Laboratories
  • Lonza Group
  • Teva Pharmaceutical Industries

第22章 関連レポート

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR4885

About Active Pharmaceutical Ingredients

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.

TechNavio's analysts forecast the Global Active Pharmaceutical Ingredients market to grow at a CAGR of 7.48 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Active Pharmaceutical Ingredients market during the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of active pharmaceutical ingredients by vendors in the market. The report provides the vendor landscape and a corresponding detailed analysis of the top seven vendors in the market. The market segmentation data and analysis is also provided for the following segmentation types: type of production process, type of product, type of player, and geography.

In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, the Global Active Pharmaceutical Ingredients Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Aurobindo Pharma
  • BASF
  • Boehringer Ingelheim
  • Cipla
  • Dr. Reddy's Laboratories
  • Lonza Group
  • Teva Pharmaceutical Industries

Other Prominent Vendors

  • Abbott Laboratories
  • Actavis
  • Aesica
  • Albemarle
  • AMPAC Fine Chemicals
  • Anhui Biochem United Pharmaceutical
  • Anuh Pharma
  • Aptuit
  • AstraZeneca
  • Biocon
  • Bristol-Myers Squibb
  • Calyx Chemicals & Pharmaceuticals
  • Cambrex
  • Cilag
  • CIRON Drugs and Pharmaceuticals
  • CTX Life Sciences
  • Dishman Pharmaceuticals & Chemicals
  • Dr. Paul Lohmann
  • Emcure Pharmaceuticals
  • Farmabios
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Guilin Pharmaceutical
  • Hetero Drugs
  • Hospira
  • Ipca Laboratories
  • Janssen Pharmaceutica
  • Johnson Matthey
  • Laurus Labs
  • Lupin
  • Mallinckrodt Pharmaceuticals
  • Mangalam Drugs & Organics
  • Merck
  • Mylan
  • Novartis
  • Novasep
  • Pen Tsao Chemical Industry
  • Pfizer
  • Ranbaxy Laboratories
  • Royal DSM
  • Sanofi-Aventis
  • Sequent Scientific
  • Shanghai Desano Chemical Pharmaceutical
  • Shasun
  • Shijiazhuang Lonzeal Pharmaceuticals
  • Sigma-Aldrich
  • ST Pharm
  • Sun Pharmaceutical Industries
  • WuXi AppTec
  • Zhejiang Langhua Pharmaceutical
  • Zhuhai Rundu Pharmaceutical

Market Driver

  • Increase in Outsourcing Activities
  • For a full, detailed list, view our report

Market Challenge

  • Decrease in R&D Spending
  • For a full, detailed list, view our report

Market Trend

  • Emergence of Africa
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview

07. Global Active Pharmaceutical Ingredients Market

  • 07.1. Market Size and Forecast
  • 07.2. Five Forces Analysis

08. Market Segmentation by Type of Production Process

  • 08.1. Global Market for Synthetically Produced Active Pharmaceutical Ingredients
    • 08.1.1. Market Size and Forecast
  • 08.2. Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients
    • 08.2.1. Market Size and Forecast
    • 08.2.2. Market Segmentation by Type of Product

09. Market Segmentation by Type of Product

  • 09.1. Global High-potency Active Pharmaceutical Ingredients Market
    • 09.1.1. Market Size and Forecast
    • 09.1.2. Market Segmentation by Type of Production Process
    • 09.1.3. Market Segmentation by Type of Product

10. Market Segmentation by Type of Player

  • 10.1. Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product

11. Geographical Segmentation

  • 11.1. Active Pharmaceutical Ingredients Market in Americas
    • 11.1.1. Market Size and Forecast
  • 11.2. Active Pharmaceutical Ingredients Market in APAC Region
    • 11.2.1. Market Size and Forecast
  • 11.3. Active Pharmaceutical Ingredients Market in EMEA Region
    • 11.3.1. Market Size and Forecast

12. Key Leading Countries

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

  • 20.1. Competitive Scenario
    • 20.1.1. Key News
  • 20.2. Key Vendors 2014
  • 20.3. Other Prominent Vendors
    • 20.3.1. Abbott Laboratories
    • 20.3.2. Actavis
    • 20.3.3. Aesica
    • 20.3.4. Albemarle
    • 20.3.5. AMPAC Fine Chemicals
    • 20.3.6. Anhui Biochem United Pharmaceutical
    • 20.3.7. Anuh Pharma
    • 20.3.8. Aptuit
    • 20.3.9. AstraZeneca
    • 20.3.10. Biocon
    • 20.3.11. Bristol-Myers Squibb
    • 20.3.12. Calyx Chemicals & Pharmaceuticals
    • 20.3.13. Cambrex
    • 20.3.14. Cilag
    • 20.3.15. CIRON Drugs and Pharmaceuticals
    • 20.3.16. CTX Life Sciences
    • 20.3.17. Dishman Pharmaceuticals & Chemicals
    • 20.3.18. Dr. Paul Lohmann
    • 20.3.19. Emcure Pharmaceuticals
    • 20.3.20. Farmabios
    • 20.3.21. F. Hoffmann-La Roche
    • 20.3.22. GlaxoSmithKline
    • 20.3.23. Guilin Pharmaceutical
    • 20.3.24. Hetero Drugs
    • 20.3.25. Hospira
    • 20.3.26. Ipca Laboratories
    • 20.3.27. Janssen Pharmaceutica
    • 20.3.28. Johnson Matthey
    • 20.3.29. Laurus Labs
    • 20.3.30. Lupin
    • 20.3.31. Mallinckrodt Pharmaceuticals
    • 20.3.32. Mangalam Drugs & Organics
    • 20.3.33. Merck
    • 20.3.34. Mylan
    • 20.3.35. Novartis
    • 20.3.36. Novasep
    • 20.3.37. Pen Tsao Chemical Industry
    • 20.3.38. Pfizer
    • 20.3.39. Ranbaxy Laboratories
    • 20.3.40. Royal DSM
    • 20.3.41. Sanofi-Aventis
    • 20.3.42. Sequent Scientific
    • 20.3.43. Shanghai Desano Chemical Pharmaceutical
    • 20.3.44. Shasun
    • 20.3.45. Shijiazhuang Lonzeal Pharmaceuticals
    • 20.3.46. Sigma-Aldrich
    • 20.3.47. ST Pharm
    • 20.3.48. Sun Pharmaceutical Industries
    • 20.3.49. WuXi AppTec
    • 20.3.50. Zhejiang Langhua Pharmaceutical
    • 20.3.51. Zhuhai Rundu Pharmaceutical

21. Key Vendor Analysis

  • 21.1. Aurobindo Pharma
    • 21.1.1. Key Facts
    • 21.1.2. Business Overview
    • 21.1.3. Business Segmentation
    • 21.1.4. Geographical Segmentation by Revenue 2014
    • 21.1.5. Business Strategy
    • 21.1.6. Recent Developments
    • 21.1.7. SWOT Analysis
  • 21.2. BASF
    • 21.2.1. Key Facts
    • 21.2.2. Business Overview
    • 21.2.3. Business/Product Segmentation
    • 21.2.4. Business Segmentation by Revenue 2012 and 2013
    • 21.2.5. Geographical Segmentation by Revenue 2013
    • 21.2.6. Business Strategy
    • 21.2.7. Recent Developments
    • 21.2.8. SWOT Analysis
  • 21.3. Boehringer Ingelheim
    • 21.3.1. Key Facts
    • 21.3.2. Business Overview
    • 21.3.3. Business Segmentation by Revenue 2013
    • 21.3.4. Business Segmentation by Revenue 2012 and 2013
    • 21.3.5. Geographical Segmentation by Revenue 2013
    • 21.3.6. Business Strategy
    • 21.3.7. Recent Developments
    • 21.3.8. SWOT Analysis
  • 21.4. Cipla
    • 21.4.1. Key Facts
    • 21.4.2. Business Overview
    • 21.4.3. Product Segmentation
    • 21.4.4. Geographical Segmentation by Revenue 2014
    • 21.4.5. Business Strategy
    • 21.4.6. Recent Developments
    • 21.4.7. SWOT Analysis
  • 21.5. Dr. Reddy's Laboratories
    • 21.5.1. Key Facts
    • 21.5.2. Business Overview
    • 21.5.3. Business Segmentation by Revenue 2014
    • 21.5.4. Business Segmentation by Revenue 2013 and 2014
    • 21.5.5. Geographical Segmentation by Revenue 2014
    • 21.5.6. Business Strategy
    • 21.5.7. Recent Developments
    • 21.5.8. SWOT Analysis
  • 21.6. Lonza Group
    • 21.6.1. Key Facts
    • 21.6.2. Business Overview
    • 21.6.3. Business Segmentation by Revenue 2013
    • 21.6.4. Business Segmentation by Revenue 2012 and 2013
    • 21.6.5. Geographical Segmentation by Revenue 2013
    • 21.6.6. Business Strategy
    • 21.6.7. Recent Developments
    • 21.6.8. SWOT Analysis
  • 21.7. Teva Pharmaceutical Industries
    • 21.7.1. Key Facts
    • 21.7.2. Business Overview
    • 21.7.3. Business Segmentation
    • 21.7.4. Business Segmentation by Revenue 2013
    • 21.7.5. Business Segmentation by Revenue 2012 and 2013
    • 21.7.6. Sales by Geography
    • 21.7.7. Business Strategy
    • 21.7.8. Key Developments
    • 21.7.9. SWOT Analysis

22. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Active Pharmaceutical Ingredients Market Segmentation
  • Exhibit 3: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process
  • Exhibit 4: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product
  • Exhibit 5: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player
  • Exhibit 6: Global Active Pharmaceutical Ingredients Market Segmentation by Geography
  • Exhibit 7: Global Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
  • Exhibit 8: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
  • Exhibit 9: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014-2019
  • Exhibit 10: Global Market for Synthetically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
  • Exhibit 11: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
  • Exhibit 12: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients: Segmentation by Type of Product 2014
  • Exhibit 13: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
  • Exhibit 14: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014-2019
  • Exhibit 15: Global High-potency Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
  • Exhibit 16: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
  • Exhibit 17: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
  • Exhibit 18: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player 2014
  • Exhibit 19: Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
  • Exhibit 20: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014
  • Exhibit 21: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014-2019
  • Exhibit 22: Active Pharmaceutical Ingredients Market in Americas 2014-2019 (US$ billion)
  • Exhibit 23: Active Pharmaceutical Ingredients Market in Americas: Segmentation by Key Leading Country 2014
  • Exhibit 24: Active Pharmaceutical Ingredients Market in APAC Region 2014-2019 (US$ billion)
  • Exhibit 25: Active Pharmaceutical Ingredients Market in APAC Region: Segmentation by Key Leading Country 2014
  • Exhibit 26: Active Pharmaceutical Ingredients Market in EMEA Region 2014-2019 (US$ billion)
  • Exhibit 27: Active Pharmaceutical Ingredients Market in EMEA Region: Segmentation by Key Leading Countries 2014
  • Exhibit 28: Global Active Pharmaceutical Ingredients Market: Key Leading Countries 2014
  • Exhibit 29: WHO's List of Prequalified Active Pharmaceutical Ingredients (22nd October, 2014)
  • Exhibit 30: Aurobindo Pharma: Business Segmentation
  • Exhibit 31: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
  • Exhibit 32: BASF: Business Segmentation 2013
  • Exhibit 33: BASF: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 34: BASF: Geographical Segmentation by Revenue 2013
  • Exhibit 35: Boehringer Ingelheim: Business Segmentation by Revenue 2013
  • Exhibit 36: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 37: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
  • Exhibit 38: Cipla: Product Segmentation
  • Exhibit 39: Cipla: Geographical Segmentation by Revenue 2014
  • Exhibit 40: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2014
  • Exhibit 41: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
  • Exhibit 42: Dr. Reddy's Laboratories: Geographical Segmentation by Revenue 2014
  • Exhibit 43: Lonza Group: Business Segmentation by Revenue 2013
  • Exhibit 44: Lonza Group: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 45: Lonza Group: Geographical Segmentation by Revenue 2013
  • Exhibit 46: Teva Pharmaceutical Industries: Business Segmentation
  • Exhibit 47: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
  • Exhibit 48: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 49: Teva Pharmaceutical Industries: Sales by Geography 2013
Back to Top